2022 BioCap Conference Pitching Competition Finalists Announced
After much deliberation and with a strong cohort of contenders, Bionow is delighted to announce the pitching competition finalists for this year’s BioCap Conference.
About BioCap
BioCap is a highlight in the northern life sciences calendar, bringing together those looking to invest in innovative companies and businesses seeking investment. The event provides a unique meeting place connecting life sciences businesses, researchers, and investors, offering a great opportunity to further discuss future collaborations.
The event takes place at Alderley Park on 22nd September with an Investor Dinner on the evening of 21st September, providing an opportunity to build valuable connections ahead of the BioCap conference.
About the pitching competition
The pitching competition invited established life science businesses who were seeking or shortly starting to seek funding of £250k or above to apply for the opportunity to present to a panel of investors their company overview, request and need for funding in an eight-minute digital pitch.
The competition was fierce, and the judging panel were once again impressed by the volume and quality of the applications.
The finalists are:
- Apini Therapeutics
- KOKU Health
- MetalloBio
- ReNewVax
- ESP Diagnostics
- PulmoBioMed
- Microneedle Solutions
- Spotlight Pathology
- Bitrobius Genetics
- Ovagen Group
- VIDIIA
The winners of the pitching competition will be announced during the BioCap conference on 22nd September.
We would like to thank all of the organisations who submitted an application and we look forward to seeing you all at the conference.
Investors attending BioCap 2022
Alpha Blue Ocean, Ascension Life Fund, Bamburgh Capital, Barking and Dagenham, Better Capital, Bonaccord, British Patient Capital, Catapult Ventures, China Investors Club, Crescent Ridge, Debiopharm International SA, Deepbridge Capital, DSW Ventures, Earlymarket, Epidarex Capital, Equity Gap, Exscientia, Foresight Group, Fund Her North, Future Planet Capital, Gimv, Go Global World Inc., GSK, IHSN, IPF Partners, Kindred Capital, Kreos Capital, LYVA Labs, Medows Sarl, Meltwind Advisory LLP, Mercia Asset Management, MSIF, Norgine Ventures, Northern Gritstone, North Wales, NorthEdge Capital, o2h Technology, Oyster Venture Partners, Panakes Partners SGRSpa, Praetura Ventures, Seventure Partners, SP Angel Corporate Finance, Stout, Ventac Partners, WG Partners LLPand more to follow…
Find out more and register here.
BioCap 2022 is supported by Slater Heelis, Bruntwood SciTech, RSM UK and Appleyard Lees.
